APA

Nair P. M., Starkey M. R., Haw T. J., Liu G., Collison A. M., Mattes J., Wark P. A., Morris J. C., Verrills N. M., Clark A. R., Ammit A. J. & Hansbro P. M. (2019). Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease. : Clinical & translational immunology.

Chicago

Nair Prema M, Starkey Malcolm R, Haw Tatt Jhong, Liu Gang, Collison Adam M, Mattes Joerg, Wark Peter A, Morris Jonathan C, Verrills Nikki M, Clark Andrew R, Ammit Alaina J and Hansbro Philip M. 2019. Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease. : Clinical & translational immunology.

Harvard

Nair P. M., Starkey M. R., Haw T. J., Liu G., Collison A. M., Mattes J., Wark P. A., Morris J. C., Verrills N. M., Clark A. R., Ammit A. J. and Hansbro P. M. (2019). Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease. : Clinical & translational immunology.

MLA

Nair Prema M, Starkey Malcolm R, Haw Tatt Jhong, Liu Gang, Collison Adam M, Mattes Joerg, Wark Peter A, Morris Jonathan C, Verrills Nikki M, Clark Andrew R, Ammit Alaina J and Hansbro Philip M. Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease. : Clinical & translational immunology. 2019.